Clinical Trials Logo

Clinical Trial Summary

The purpose of this research study is to measure the effects of the drug, esomeprazole 40 mg (Nexium) or placebo (inactive drug) on vocal cord granulomas.


Clinical Trial Description

Vocal cord granulomas (VCG) are common structural lesions of vocal cords attributed to vocal abuse / misuse and recently to gastroesophageal reflux. Vocal process granulomas are reactive/reparative process, in which an intact or ulcerated squamous epithelium is underlaid by granulation tissue or fibrosis (4, 5). Ulualp et al (6) have reported a higher prevalence of pharyngeal acid reflux (PAR) events in patients with vocal cord lesions. In a case control study they showed that the prevalence of pharyngeal reflux, documented with 3 site pharyngoesophageal pH monitoring, is higher among patients with posterior laryngitis and vocal cord lesions than control (78% vs. 21%). Most recently our cohort trial in over 80 patients with laryngeal findings suggestive of GERD suggested that vocal cord abnormalities such as granulomas may be more specific sign of GERD than any other (7). Thus, there is reasonable scientific intrigue regarding this laryngeal finding and the causal role from gastroesophagopharyngeal acid reflux requiring better studies. However, no study has evaluated the potential causal association between GERD and VCGs. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00567658
Study type Interventional
Source Vanderbilt University
Contact
Status Withdrawn
Phase Phase 3
Start date February 2008
Completion date January 2010

See also
  Status Clinical Trial Phase
Completed NCT00372918 - Interpretation of Transnasal Esophagoscopy Findings Phase 4
Completed NCT00373997 - Esophageal and Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux Phase 4
Completed NCT00388453 - Efficacy of Dx-pH Probe in Diagnosing Extra-esophageal Reflux Disease Phase 3
Enrolling by invitation NCT03269396 - Laryngeal Allograft Transplantation N/A
Recruiting NCT04734483 - The Effectiveness of Reconstructive Microsurgery on the Clinical and Functional State of Laryngeal Stenosis N/A
Completed NCT00444145 - Do Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux Predict Response to Treatment? Phase 4
Completed NCT01360580 - Swallowing Disorders After Prolonged Mechanical Ventilation N/A
Completed NCT00335283 - Efficacy of Lansoprazole in Chronic Post Nasal Drip Phase 3
Completed NCT03843580 - Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) Could Decrease the Incidence of Oxygen Desaturation During Suspension Laryngoscopy: a Randomized Controlled Trial (Optilaryngo) N/A